In addition to the cell-autonomous migration-promoting effect of p110α on LECs observed in vitro, lymphangiogenic VEGF-C/VEGFR3 signaling in the LM lesion was found to significantly contribute to the further vascular growth of the lesions in vivo. The gene discussed is FLT4; the disease is lymphangioma.